SCHEMBL3160809

SCHEMBL3160809

CC(C)(C)OC(=O)CCNCc1ccc(N/C(=C2\C(=O)Nc3cc(C(N)=O)ccc32)c2ccccc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.36
OPRD1 P41143 3/20 0.36
OPRK1 P41145 3/20 0.36
BACE1 P56817 2/20 0.34
S1PR1 P21453 2/20 0.33
CTNNB1 P35222 1/20 0.33
TCF7L2 Q9NQB0 1/20 0.33
HDAC1 Q13547 3/20 0.33
PTPRC P08575 2/20 0.33
ROCK2 O75116 2/20 0.33
HDAC6 Q9UBN7 1/20 0.33
LTA4H P09960 1/20 0.33
PDCD1 Q15116 1/20 0.32
CD274 Q9NZQ7 1/20 0.32
NR1H2 P55055 1/20 0.32
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A3 Q01959 1/20 0.32
GRIN1 Q05586 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3147765 0.94 LTA4H (0.36) BACE1S1PR1CTNNB1TCF7L2HDAC1
SCHEMBL2572833 0.93 HIF1A (0.38) BACE1MAPTNAMPT
SCHEMBL4493463 0.91 FPR2 (0.34) S1PR1CTNNB1TCF7L2HDAC1PDCD1
SCHEMBL3159980 0.91 MAPT (0.43) MAPTNAMPT
SCHEMBL4486527 0.90 SLC2A1 (0.34) PDCD1CD274
SCHEMBL4498038 0.90 BACE1 (0.38) BACE1S1PR1CTNNB1TCF7L2PDCD1
SCHEMBL4482769 0.88 KDR (0.35) ROCK2PDCD1CD274NAMPT
SCHEMBL30708636 0.85 BACE1 (0.41) OPRM1OPRD1OPRK1BACE1ROCK2
SCHEMBL2566851 0.84 BACE1 (0.39) OPRM1OPRD1OPRK1BACE1HDAC1
SCHEMBL2566854 0.84 BACE1 (0.39) OPRM1OPRD1OPRK1BACE1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2157081-A1 Indolinones substituted in six locations, their manufacture and their application as medicine Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2010-02-24 EP disclosed
US-6762180-B1 Substituted indolines which inhibit receptor tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-07-13 US disclosed
EP-1224170-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT Boehringer Ingelheim Pharma KG (DE) 2002-07-24 EP disclosed
WO-2001027081-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-04-19 WO disclosed